Literature DB >> 32795110

Antigen physiochemical properties allosterically effect the IgG Fc-region and Fc neonatal receptor affinity.

Yue Sun1, Alberto Estevez2, Tilman Schlothauer3,4, Aaron T Wecksler1.   

Abstract

The neonatal Fc receptor (FcRn) is a key membrane protein that plays an integral role in serum immunoglobulin (IgG) recycling, which extends the half-life of antibody. In addition, FcRn is known to traffic antigen-bound immunoglobulins (Ag-IgGs), and to interact with immune complexes to facilitate the antigen cross-presentation of peptides derived from the immune complexes in antigen-presenting cells (APCs). Studies on the IgG-FcRn molecular interactions have primarily focused on the Fc region, and only recently have shown the potential impact of the antigen-binding fragment physiochemical properties on FcRn binding. However, the effect of the antigen physiochemical properties on IgG structure as it relates to Ag-IgG-FcRn binding is not well understood. Here we used an IgG-peptide antigen complex as a model system to investigate the structural effects of the antigen's physiochemical properties on the IgG structure, and the subsequent effects of Ag-IgG-FcRn interactions. We used hydroxyl radical footprinting-mass spectrometry to investigate the structural impact on an IgG upon antigen binding, and observed that the physicochemical properties of the antigen differentially induce conformational changes in the IgG FcRn binding region. The extent of these structural changes directly correlates to the magnitude of the affinity differences between the Ag-IgG complexes and FcRn. Moreover, the antigen's physicochemical properties differentially induce structural differences within the Ag-IgG-FcRn ternary complex. We also provide electron microscopy data that shows corroborating Fab-FcRn interactions, and confirms the hypothesis of potential 2:1 FcRn:IgG binding stoichiometry. These data demonstrate antigen-induced Fc structural rearrangements affect both the affinity toward FcRn and the trimeric antigen-IgG-FcRn complex, providing novel molecular insights in the first steps toward understanding interactions of FcRn-containing large(r)-sized immune complex.

Entities:  

Keywords:  Fc neonatal receptor; Immunoglobulin; antigen-induced allosteric effects; hydroxyl radical footprinting-mass spectrometry; negative stain electron microscopy

Year:  2020        PMID: 32795110      PMCID: PMC7531492          DOI: 10.1080/19420862.2020.1802135

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  41 in total

1.  Conformational changes in the antibody constant domains upon hapten-binding.

Authors:  Takuma Sagawa; Masayuki Oda; Hisayuki Morii; Hisao Takizawa; Haruo Kozono; Takachika Azuma
Journal:  Mol Immunol       Date:  2005-01       Impact factor: 4.407

Review 2.  FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.

Authors:  Michal Pyzik; Timo Rath; Wayne I Lencer; Kristi Baker; Richard S Blumberg
Journal:  J Immunol       Date:  2015-05-15       Impact factor: 5.422

Review 3.  Chapter 4: Multitasking by exploitation of intracellular transport functions the many faces of FcRn.

Authors:  E Sally Ward; Raimund J Ober
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

4.  Crystal structure of the complex of rat neonatal Fc receptor with Fc.

Authors:  W P Burmeister; A H Huber; P J Bjorkman
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

5.  Evidence of allosteric conformational changes in the antibody constant region upon antigen binding.

Authors:  Masayuki Oda; Haruo Kozono; Hisayuki Morii; Takachika Azuma
Journal:  Int Immunol       Date:  2003-03       Impact factor: 4.823

6.  Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor.

Authors:  W P Burmeister; L N Gastinel; N E Simister; M L Blum; P J Bjorkman
Journal:  Nature       Date:  1994-11-24       Impact factor: 49.962

7.  Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.

Authors:  Stefka B Petkova; Shreeram Akilesh; Thomas J Sproule; Gregory J Christianson; Hana Al Khabbaz; Aaron C Brown; Leonard G Presta; Y Gloria Meng; Derry C Roopenian
Journal:  Int Immunol       Date:  2006-10-31       Impact factor: 4.823

8.  Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer.

Authors:  Kristi Baker; Timo Rath; Magdalena B Flak; Janelle C Arthur; Zhangguo Chen; Jonathan N Glickman; Inti Zlobec; Eva Karamitopoulou; Matthew D Stachler; Robert D Odze; Wayne I Lencer; Christian Jobin; Richard S Blumberg
Journal:  Immunity       Date:  2013-11-27       Impact factor: 31.745

Review 9.  The Neonatal Fc Receptor (FcRn): A Misnomer?

Authors:  Michal Pyzik; Kine M K Sand; Jonathan J Hubbard; Jan Terje Andersen; Inger Sandlie; Richard S Blumberg
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

10.  Antigen binding allosterically promotes Fc receptor recognition.

Authors:  Jun Zhao; Ruth Nussinov; Buyong Ma
Journal:  MAbs       Date:  2018-10-05       Impact factor: 5.857

View more
  4 in total

1.  Affinity Selection in Germinal Centers: Cautionary Tales and New Opportunities.

Authors:  Jose Faro; Mario Castro
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

2.  The Fab portion of immunoglobulin G has sites in the CL domain that interact with Fc gamma receptor IIIa.

Authors:  Yuki Yamaguchi; Natsumi Wakaizumi; Mine Irisa; Takahiro Maruno; Mari Shimada; Koya Shintani; Haruka Nishiumi; Rina Yogo; Saeko Yanaka; Daisuke Higo; Tetsuo Torisu; Koichi Kato; Susumu Uchiyama
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

3.  Biophysical differences in IgG1 Fc-based therapeutics relate to their cellular handling, interaction with FcRn and plasma half-life.

Authors:  Rahel Frick; Simone Mester; Torleif Tollefsrud Gjølberg; Stian Foss; Algirdas Grevys; Lene Støkken Høydahl; Øystein Kalsnes Jørstad; Tilman Schlothauer; Inger Sandlie; Morten C Moe; Jan Terje Andersen
Journal:  Commun Biol       Date:  2022-08-18

Review 4.  In Translation: FcRn across the Therapeutic Spectrum.

Authors:  Timothy Qi; Yanguang Cao
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.